“What’s Next for Immunotherapies?” by Anas Younes

Anas Younes shared a post on LinkedIn: Immunotherapies Immunotherapies

“My interview with Mark Cobbold, Senior Vice President of Discovery, Immuno-Oncology, and Head of Oncology Cell Therapy, Oncology R&D, AstraZeneca.”  .

Source: Anas Younes/LinkedIn

Anas Younes is the Senior Vice President and Global Head of Hematology (Early and Late Stage) Oncology R&D at AstraZeneca. Prior to working for AstraZeneca, he was the Chief of the Lymphoma Service at Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, and a Professor of Medicine at the University of Texas MD Anderson Cancer Center, Houston, TX. His interests include HL, NHL, developing novel targeted therapies for lymphoma, identification of biomarkers for treatment, and participation in clinical trials.